Related Experiment Video
Updated: May 24, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Sharps disposal practices among diabetic patients using insulin
Dhanalutchmee Govender1, Andrew Ross
1Department of Family Medicine, University of KwaZulu-Natal, Durban. shaunandmicci@hotmail.com
Summary
Diabetic patients need education on safe sharps disposal to prevent needle injuries. Healthcare providers and guidelines must ensure proper sharps disposal education for all insulin-dependent individuals.
Area of Science:
- Endocrinology
- Public Health
- Patient Safety
Background:
- Insulin-dependent diabetic patients frequently use sharps like needles for self-administration.
- Lack of education on safe sharps disposal leads to improper disposal practices.
- Unsafe sharps disposal poses risks of needle-stick injuries and disease transmission.
Purpose of the Study:
- To highlight the critical need for comprehensive sharps disposal education for diabetic patients.
- To emphasize the role of healthcare professionals in patient education regarding sharps disposal.
- To advocate for clear guidelines on safe needle disposal in South Africa.
Main Methods:
- Review of current practices and educational gaps in sharps disposal for diabetic patients.
- Analysis of healthcare provider responsibilities in patient counseling.
- Assessment of existing treatment guidelines for sharps disposal recommendations.
Main Results:
- Diabetic patients often lack adequate knowledge of safe sharps disposal methods.
- Healthcare providers (doctors, nurses, pharmacists) are key educators for safe sharps disposal.
- Current South African guidelines may require clearer directives on needle disposal.
Conclusions:
- Appropriate education on safe sharps disposal must be integrated into diabetic patient counseling.
- Healthcare professionals must actively educate and reinforce safe sharps disposal practices.
- Updated and clear guidance in national treatment guidelines is essential for safe needle management.
Related Concept Videos
Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
SBAR II: Application of SBAR
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
